The Science We Fund
We are about one thing: funding the most promising research that will make it from a lab to a child’s bedside in the shortest amount of time possible.
Cookies for Kids’ Cancer has granted over $21 million to date, funding over 130 research projects that have resulted in 25 treatments and clinical trials available to children today.
Our Clinical Trials and Grants Since 2008
2019
| AMOUNT | CENTER | RESEARCHER | GRANT NAME | CATEGORY | TYPE OF CANCER | ||
| $100,000 | Seattle's Children Hospital | Dr. Marie Bleakley | Immunotherapy for Infant Leukemia - Extension Application | Blood Cancer | Blood Cancer | ||
| $200,000 | Dana-Farber Cancer Institute |
|
| Blood Cancer | Leukemia/ Lymphoma | ||
| $143,500 | Children's Oncology Group | $200,000 | |||||
| $150,000 | Children's Hospital Of Philadelphia | Dr. Yael Mosse | Clinical Development of Next Generation ALK inhibitor lorlatinib for patients with ALK-driven neuroblastomas | Solid and Bone Cancers | Neuroblastoma | ||
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
| Amount | Center | Researcher | Grant Name | Year | Type of Cancer |
| $200,000 | Fred Hutchinson Cancer Research Center | Dr. Marie Bleakley | Immunotherapy for Infant Leukemia | 2017 | Blood Cancer, Leukemia |
| $200,000 | UCSF Benioff Children's Hospital | Dr. Mignon Loh | Identifying Targeted Therapeutics in Juvenile Myelomonocytic Leukemia | 2017 | Blood Cancer, Leukemia |
| $100,000 | St. Jude Children's Research Hospital | Dr. Jeffrey Rubnitz | Pilot study of microtransplantation in pediatric patients with refractory or relapsed acute myeloid leukemia | 2015 | Blood Cancer, Leukemia |
| $100,000 | Children's Hospital of Philadelphia | Dr. Aplenc | Chimeric antigen receptor T cell immunotherapy for pediatric acute myeloid leukemia | 2014 | Blood Cancer, Leukemia |
| $100,000 | St. Jude Children's Research Hospital | Dr. Inaba | Genetic characterization and therapeutic targeting of pediatric mixed phenotype acute leukemia | 2014 | |